HEADER MEMBRANE PROTEIN 17-JUN-21 7F47 TITLE CRYO-EM STRUCTURE OF RHIZOBIUM ETLI MPRF COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOTHETICAL CONSERVED PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RHIZOBIUM ETLI (STRAIN CFN 42 / ATCC 51251); SOURCE 3 ORGANISM_TAXID: 347834; SOURCE 4 GENE: RHE_CH03486; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PTSP1 KEYWDS FLIPPASE, AMINOACYL-TRNA, PHOSPHATIDYLGLYCEROL, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR M.NISHIMURA,H.HIRANO,K.KOBAYASHI,C.P.GILL,C.N.K.PHAN,Y.KISE, AUTHOR 2 T.KUSAKIZAKO,K.YAMASHITA,Y.ITO,H.ROY,T.NISHIZAWA,O.NUREKI REVDAT 2 29-JUN-22 7F47 1 REMARK REVDAT 1 22-JUN-22 7F47 0 JRNL AUTH M.NISHIMURA JRNL TITL CRYO-EM STRUCTURE OF RHIZOBIUM ETLI MPRF JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, SERIALEM, CTFFIND, COOT, REMARK 3 RELION, RELION, RELION, REFMAC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 5VRV REMARK 3 REFINEMENT SPACE : RECIPROCAL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.990 REMARK 3 NUMBER OF PARTICLES : 307241 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7F47 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JUN-21. REMARK 100 THE DEPOSITION ID IS D_1300022801. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : MPRF REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 6.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : A WAITING TIME OF 10 S AND A REMARK 245 BLOTTING TIME OF 4 S REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 8.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 3159 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5600.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : CDS MODE REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 THE ASSEMBLY REPRESENTED IN THIS ENTRY HAS REGULAR REMARK 300 CYCLIC POINT SYMMETRY (SCHOENFLIES SYMBOL = C2). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 193.22401 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 193.22401 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 GLY A 3 REMARK 465 HIS A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 LEU A 7 REMARK 465 GLU A 8 REMARK 465 GLU A 9 REMARK 465 MET A 10 REMARK 465 GLU A 11 REMARK 465 ALA A 12 REMARK 465 THR A 13 REMARK 465 ASP A 14 REMARK 465 GLY A 15 REMARK 465 PHE A 16 REMARK 465 SER A 17 REMARK 465 PHE A 18 REMARK 465 ARG A 19 REMARK 465 THR A 20 REMARK 465 LEU A 21 REMARK 465 PHE A 22 REMARK 465 ARG A 23 REMARK 465 ARG A 24 REMARK 465 TYR A 25 REMARK 465 ARG A 323 REMARK 465 ARG A 324 REMARK 465 PHE A 325 REMARK 465 VAL A 326 REMARK 465 ASP A 327 REMARK 465 GLY A 792 REMARK 465 MET A 793 REMARK 465 SER A 794 REMARK 465 LYS A 795 REMARK 465 ARG A 796 REMARK 465 GLU A 797 REMARK 465 LYS A 867 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR A 539 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 117 -92.00 -128.37 REMARK 500 ALA A 121 -13.28 83.11 REMARK 500 PHE A 209 50.17 -103.00 REMARK 500 GLN A 246 165.12 175.89 REMARK 500 THR A 247 24.57 -144.06 REMARK 500 ILE A 249 -65.49 -108.97 REMARK 500 TYR A 376 -78.96 -110.95 REMARK 500 ALA A 429 16.01 -156.63 REMARK 500 ALA A 462 -165.05 77.22 REMARK 500 ARG A 529 128.26 -39.57 REMARK 500 PHE A 533 -126.88 52.78 REMARK 500 ASP A 592 154.99 67.16 REMARK 500 PHE A 709 -83.30 72.82 REMARK 500 PHE A 714 85.15 -68.77 REMARK 500 ASP A 751 -85.36 -112.48 REMARK 500 SER A 841 -73.08 -73.24 REMARK 500 ASN A 845 121.73 -170.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-31445 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF RHIZOBIUM ETLI MPRF DBREF 7F47 A 1 867 UNP Q2K4J4 Q2K4J4_RHIEC 1 867 SEQADV 7F47 MET A 10 UNP Q2K4J4 ILE 10 CONFLICT SEQRES 1 A 867 MET SER GLY HIS GLY ASN LEU GLU GLU MET GLU ALA THR SEQRES 2 A 867 ASP GLY PHE SER PHE ARG THR LEU PHE ARG ARG TYR ARG SEQRES 3 A 867 THR PRO LEU THR ALA ALA ALA THR LEU ILE VAL PHE CYS SEQRES 4 A 867 LEU VAL GLY TYR ALA ILE MET GLN LEU THR ASN GLU VAL SEQRES 5 A 867 ARG TYR ASP ASP VAL VAL ALA ALA LEU ALA ALA THR GLY SEQRES 6 A 867 PRO SER ALA ILE LEU LEU ALA LEU PHE PHE THR ALA LEU SEQRES 7 A 867 SER PHE LEU SER LEU VAL PHE TYR ASP LEU ASN ALA ILE SEQRES 8 A 867 GLU TYR ILE GLY LYS LYS LEU PRO PHE PRO HIS VAL ALA SEQRES 9 A 867 LEU THR ALA PHE SER ALA TYR ALA VAL GLY ASN THR ALA SEQRES 10 A 867 GLY PHE GLY ALA LEU SER GLY GLY ALA ILE ARG TYR ARG SEQRES 11 A 867 ALA TYR THR ARG LEU GLY LEU SER PRO GLU ASP ILE GLY SEQRES 12 A 867 ARG ILE ILE ALA PHE VAL THR LEU SER PHE GLY LEU GLY SEQRES 13 A 867 LEU ALA ALA VAL ALA SER ILE ALA LEU ILE ILE ILE ALA SEQRES 14 A 867 SER GLU ILE GLY PRO LEU ILE GLY VAL SER PRO PHE LEU SEQRES 15 A 867 LEU ARG LEU ILE ALA GLY SER ILE ILE ALA ILE LEU GLY SEQRES 16 A 867 ALA VAL MET ILE ILE GLY ARG GLU GLY ARG VAL LEU ASN SEQRES 17 A 867 PHE GLY ALA VAL ALA ILE ARG LEU PRO ASP SER ARG THR SEQRES 18 A 867 TRP SER ARG GLN PHE LEU VAL THR ALA PHE ASP ILE ALA SEQRES 19 A 867 ALA SER ALA SER VAL LEU TYR VAL LEU LEU PRO GLN THR SEQRES 20 A 867 ALA ILE GLY TRP PRO VAL PHE LEU ALA VAL TYR ALA ILE SEQRES 21 A 867 ALA VAL GLY LEU GLY VAL LEU SER HIS VAL PRO ALA GLY SEQRES 22 A 867 LEU GLY VAL PHE GLU THR VAL ILE ILE ALA SER LEU GLY SEQRES 23 A 867 SER ALA VAL ASN ILE ASP ALA VAL LEU GLY SER LEU VAL SEQRES 24 A 867 LEU TYR ARG LEU ILE TYR HIS VAL LEU PRO LEU LEU ILE SEQRES 25 A 867 ALA VAL LEU ALA VAL SER ALA ALA GLU LEU ARG ARG PHE SEQRES 26 A 867 VAL ASP HIS PRO ALA ALA SER SER VAL ARG ARG ILE GLY SEQRES 27 A 867 GLY ARG LEU MET PRO GLN LEU LEU SER THR LEU ALA LEU SEQRES 28 A 867 LEU LEU GLY VAL MET LEU VAL PHE SER SER VAL THR PRO SEQRES 29 A 867 THR PRO ASP GLN ASN LEU GLU PHE LEU SER ASN TYR LEU SEQRES 30 A 867 PRO LEU PRO MET VAL GLU GLY ALA HIS PHE LEU SER SER SEQRES 31 A 867 LEU LEU GLY LEU ALA LEU VAL VAL ALA ALA ARG GLY LEU SEQRES 32 A 867 GLY GLN ARG LEU ASP GLY ALA TRP TRP VAL ALA VAL PHE SEQRES 33 A 867 SER ALA VAL ALA ALA LEU THR LEU SER LEU LEU LYS ALA SEQRES 34 A 867 ILE ALA LEU VAL GLU ALA ALA PHE LEU ALA PHE LEU ILE SEQRES 35 A 867 PHE GLY LEU PHE VAL SER ARG ARG LEU PHE THR ARG HIS SEQRES 36 A 867 ALA SER LEU LEU ASN GLN ALA MET THR ALA SER TRP LEU SEQRES 37 A 867 MET ALA ILE ALA VAL ILE VAL VAL GLY ALA VAL VAL ILE SEQRES 38 A 867 LEU LEU PHE VAL TYR ARG ASP VAL GLU TYR SER ASN GLU SEQRES 39 A 867 LEU TRP TRP GLN PHE GLU PHE THR ALA GLU ALA PRO ARG SEQRES 40 A 867 GLY LEU ARG ALA LEU LEU GLY ILE THR ILE ILE SER SER SEQRES 41 A 867 ALA ILE ALA ILE PHE SER LEU LEU ARG PRO ALA THR PHE SEQRES 42 A 867 ARG PRO GLU PRO ALA THR GLU GLU ALA LEU THR ARG ALA SEQRES 43 A 867 VAL GLU ILE VAL ARG LYS GLN GLY ASN ALA ASP ALA ASN SEQRES 44 A 867 LEU VAL ARG MET GLY ASP LYS SER ILE MET PHE SER GLU SEQRES 45 A 867 LYS GLY ASP ALA PHE ILE MET TYR GLY ARG GLN GLY ARG SEQRES 46 A 867 SER TRP ILE ALA LEU PHE ASP PRO VAL GLY ASP HIS GLY SEQRES 47 A 867 ALA VAL GLN GLU LEU VAL TRP ARG PHE VAL GLU ALA ALA SEQRES 48 A 867 ARG ALA ALA GLY CYS ARG ALA VAL PHE TYR GLN ILE SER SEQRES 49 A 867 PRO ALA LEU LEU SER HIS CYS ALA ASP ALA GLY LEU ARG SEQRES 50 A 867 ALA PHE LYS LEU GLY GLU LEU ALA VAL ALA ASP LEU ARG SEQRES 51 A 867 THR PHE GLU MET LYS GLY GLY LYS TRP ALA ASN LEU ARG SEQRES 52 A 867 GLN THR ALA SER ARG ALA GLN ARG ASP GLY LEU GLU PHE SEQRES 53 A 867 ALA VAL VAL GLU PRO GLU ASN VAL PRO ASP ILE ILE ASP SEQRES 54 A 867 GLU LEU ALA ALA VAL SER THR ALA TRP LEU GLU HIS HIS SEQRES 55 A 867 ASN ALA LYS GLU LYS GLY PHE SER LEU GLY SER PHE ASP SEQRES 56 A 867 PRO ASP TYR VAL SER ALA GLN PRO VAL GLY ILE LEU LYS SEQRES 57 A 867 LYS ASP GLY LYS ILE VAL ALA PHE ALA ASN ILE LEU VAL SEQRES 58 A 867 THR GLU SER LYS GLU GLU GLY THR ILE ASP LEU MET ARG SEQRES 59 A 867 PHE SER PRO ASP ALA PRO LYS GLY SER MET ASP PHE LEU SEQRES 60 A 867 PHE VAL GLN ILE MET GLU TYR LEU ARG ASN GLN GLY PHE SEQRES 61 A 867 THR HIS PHE ASN LEU GLY MET ALA PRO LEU SER GLY MET SEQRES 62 A 867 SER LYS ARG GLU ALA ALA PRO VAL TRP ASP ARG ILE GLY SEQRES 63 A 867 SER THR VAL PHE GLU HIS GLY GLU ARG PHE TYR ASN PHE SEQRES 64 A 867 LYS GLY LEU ARG ALA PHE LYS SER LYS PHE HIS PRO HIS SEQRES 65 A 867 TRP GLN PRO ARG TYR LEU ALA VAL SER GLY GLY GLY ASN SEQRES 66 A 867 PRO MET ILE ALA LEU MET ASP ALA THR PHE LEU ILE GLY SEQRES 67 A 867 GLY GLY LEU LYS GLY VAL VAL ARG LYS HET PGW A 901 51 HET 1K1 A 902 60 HETNAM PGW (1R)-2-{[(S)-{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY) HETNAM 2 PGW PHOSPHORYL]OXY}-1-[(HEXADECANOYLOXY)METHYL]ETHYL (9Z)- HETNAM 3 PGW OCTADEC-9-ENOATE HETNAM 1K1 [(2R)-1-[[(2R)-3-[(2S)-2,6-BIS(AZANYL)HEXANOYL]OXY-2- HETNAM 2 1K1 OXIDANYL-PROPOXY]-OXIDANYL-PHOSPHORYL]OXY-3- HETNAM 3 1K1 HEXADECANOYLOXY-PROPAN-2-YL] (E)-OCTADEC-9-ENOATE HETSYN PGW 1-PALMITOYL-2-OLEOYL-SN-GLYCERO-3-[PHOSPHO-(1- HETSYN 2 PGW GLYCEROL)]; PHOSPHATIDYLGLYCEROL FORMUL 2 PGW C40 H77 O10 P FORMUL 3 1K1 C46 H89 N2 O11 P FORMUL 4 HOH *4(H2 O) HELIX 1 AA1 ARG A 26 THR A 49 1 24 HELIX 2 AA2 ARG A 53 THR A 64 1 12 HELIX 3 AA3 GLY A 65 GLY A 95 1 31 HELIX 4 AA4 PRO A 99 ALA A 117 1 19 HELIX 5 AA5 SER A 123 GLY A 136 1 14 HELIX 6 AA6 SER A 138 GLY A 177 1 40 HELIX 7 AA7 SER A 179 GLY A 201 1 23 HELIX 8 AA8 ARG A 202 ARG A 205 5 4 HELIX 9 AA9 ASP A 218 LEU A 244 1 27 HELIX 10 AB1 GLY A 250 HIS A 269 1 20 HELIX 11 AB2 VAL A 270 ALA A 272 5 3 HELIX 12 AB3 GLY A 273 GLY A 286 1 14 HELIX 13 AB4 ASN A 290 HIS A 306 1 17 HELIX 14 AB5 HIS A 306 LEU A 322 1 17 HELIX 15 AB6 PRO A 329 THR A 363 1 35 HELIX 16 AB7 PRO A 366 TYR A 376 1 11 HELIX 17 AB8 PRO A 378 GLN A 405 1 28 HELIX 18 AB9 LEU A 407 ILE A 430 1 24 HELIX 19 AC1 ALA A 431 SER A 448 1 18 HELIX 20 AC2 THR A 464 TYR A 486 1 23 HELIX 21 AC3 GLU A 494 GLN A 498 5 5 HELIX 22 AC4 ALA A 503 ARG A 529 1 27 HELIX 23 AC5 THR A 539 LYS A 552 1 14 HELIX 24 AC6 ASN A 555 GLY A 564 5 10 HELIX 25 AC7 ALA A 599 ALA A 614 1 16 HELIX 26 AC8 SER A 624 ALA A 626 5 3 HELIX 27 AC9 LEU A 627 ALA A 634 1 8 HELIX 28 AD1 ARG A 650 PHE A 652 5 3 HELIX 29 AD2 GLY A 656 LYS A 658 5 3 HELIX 30 AD3 TRP A 659 ASP A 672 1 14 HELIX 31 AD4 GLU A 680 ASP A 686 5 7 HELIX 32 AD5 ILE A 687 HIS A 702 1 16 HELIX 33 AD6 ASP A 715 SER A 720 1 6 HELIX 34 AD7 GLY A 762 GLY A 779 1 18 HELIX 35 AD8 ILE A 805 TYR A 817 1 13 HELIX 36 AD9 LEU A 822 LYS A 828 1 7 HELIX 37 AE1 ASN A 845 GLY A 859 1 15 SHEET 1 AA1 3 LEU A 207 ASN A 208 0 SHEET 2 AA1 3 ALA A 213 ILE A 214 -1 O ILE A 214 N LEU A 207 SHEET 3 AA1 3 TRP A 802 ASP A 803 -1 O ASP A 803 N ALA A 213 SHEET 1 AA2 3 SER A 567 PHE A 570 0 SHEET 2 AA2 3 ALA A 576 GLN A 583 -1 O TYR A 580 N SER A 567 SHEET 3 AA2 3 VAL A 594 GLY A 595 -1 O VAL A 594 N PHE A 577 SHEET 1 AA311 SER A 567 PHE A 570 0 SHEET 2 AA311 ALA A 576 GLN A 583 -1 O TYR A 580 N SER A 567 SHEET 3 AA311 SER A 586 LEU A 590 -1 O ILE A 588 N GLY A 581 SHEET 4 AA311 ARG A 617 ILE A 623 1 O VAL A 619 N ALA A 589 SHEET 5 AA311 HIS A 832 VAL A 840 -1 O TYR A 837 N ILE A 623 SHEET 6 AA311 ARG A 637 ASP A 648 -1 N VAL A 646 O HIS A 832 SHEET 7 AA311 HIS A 782 ALA A 788 -1 O PHE A 783 N ALA A 647 SHEET 8 AA311 GLU A 747 PHE A 755 1 N GLY A 748 O ASN A 784 SHEET 9 AA311 LYS A 732 LEU A 740 -1 N LEU A 740 O THR A 749 SHEET 10 AA311 VAL A 724 LYS A 729 -1 N LEU A 727 O ALA A 735 SHEET 11 AA311 LEU A 674 VAL A 679 -1 N VAL A 679 O VAL A 724 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -1.000000 0.000000 0.000000 193.22400 MTRIX2 2 0.000000 -1.000000 0.000000 193.22400 MTRIX3 2 0.000000 0.000000 1.000000 0.00000